Mission
We make high-quality chemical analysis usable beyond the laboratory.
Company
From ETH research to real-world sensing systems.
Alivion is an ETH Zurich spin-off developing application-specific chemical sensing systems around its SmartSelect™ platform.
About Alivion
Who we are.
Founded in 2020 as an ETH Zurich spin-off, Alivion turns advances in chemical sensing into reliable, application-specific measurement systems. Today, our interdisciplinary team develops and integrates SmartSelect™ for industrial and health-related partners that need high-quality chemical measurements beyond the laboratory.
Vision
A world where reliable chemical measurements become part of everyday products, processes and decisions.
-
Origins
Scientific foundation at ETH Zurich
10 years of ETH Zurich research established the sensing principles behind SmartSelect™.
-
2020
Alivion founded
An ETH Zurich spin-off created to translate advanced sensing research into real-world systems.
-
2022
First system commercialized
Spark brought SmartSelect™ to market in a handheld system for selective methanol screening.
-
2025
Expanded into breath analysis
Nutrion™ extended SmartSelect™ to guided breath-acetone monitoring and connected data.
-
Today
Partner-led integration
SmartSelect™ is now configured for integration into partner products, processes and workflows.
Team & Board
The people behind Alivion.
Alivion combines B2B leadership and deep chemical-sensing expertise with hands-on capabilities across hardware, software, product delivery and business development.
Team
Woody Schoch
Chief Executive Officer
Leads Alivion’s strategy, sales and marketing, industry partnerships and day-to-day operations. He brings more than 25 years of B2B leadership experience, including in the MedTech sector.
Dr. Jan van den Broek
Co-Founder & Chief Technology Officer
Co-founded Alivion and leads the development of the SmartSelect™ technology platform. His expertise spans sensors and electronics, AI and cloud solutions, and material science—translating research into robust sensing systems for real-world applications.
Dr. Giorgia Greter
Business Development
Drives partnerships and venture development for Alivion. She brings first-hand entrepreneurial experience from founding a biotech company, complemented by dedicated training in entrepreneurship and venture building.
Giorgio Di Loro
Lead Software Engineering
Leads software engineering at Alivion, from embedded sensor software and data processing to the applications that turn measurements into usable results. His background spans sensors and electronics as well as multidisciplinary product development.
Tobias Gruber
Lead Hardware Engineering
Leads hardware engineering at Alivion, developing and validating sensor systems for internal development and partner projects. His hands-on experience spans prototyping, system integration, validation and technical support.
Teodora Magerie
Intern
Supports business development and market analysis. She has a background in biomedical engineering.
Governance
Board of Directors
The Board combines founder continuity with experience in commercialization, entrepreneurship, investment and scaling international technology businesses.
Dr. Jan van den Broek
Chair of the Board & Co-Founder
Connects Alivion’s scientific foundation and technology strategy with its long-term development. As Chair and co-founder, he provides continuity between the company’s core technology, commercial direction and governance.
Dr. med. Kay Brunner
Board Member
Brings more than 25 years of strategic and operational leadership experience, including senior roles at Roche and Abbott. He supports Alivion on go-to-market strategy, industry partnerships, commercial due diligence and value creation.
Dr. med. dent. Erich Müller
Board Member
Combines entrepreneurial experience with the perspective of an early-stage investor. He supports Alivion on financing, company development and the creation of sustainable long-term value.
Dr. René Lenggenhager
Board Member
Brings extensive leadership experience from global technology and analytical-instrumentation companies, including Mettler Toledo, Bruker BioSpin and Comet Group. He supports Alivion on innovation management, commercial scaling and building market-oriented organizations.
Scientific Advisor
Scientific roots.
Continued collaboration.
Prof. Dr. Andreas T. Güntner
Co-Founder & Scientific Advisor
Co-founded Alivion based on sensing technology developed at ETH Zurich and continues to advise the company on chemical sensing, materials and scientific strategy. He is Assistant Professor at ETH Zurich and leads the Human-centered Sensing Laboratory.
Careers
Help build chemical sensing for the real world.
We are always interested in meeting talented, highly motivated people who share our vision of making chemical sensing usable beyond the laboratory. If you want to combine science, engineering and product development to create real-world impact, we would be glad to hear from you.
Introduce yourself
Send us a short introduction and your CV or LinkedIn profile.